TV:NYSEGrupo Televisa S.A.B. Analysis
Data as of 2026-09-16 - not real-time
$2.19
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Grupo Televisa, S.A.B. trades at $2.19, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. It has lost 20.4% over the past 30 days. RSI sits at 21.7, which reads as oversold, and MACD momentum is bearish. Watch $2.18 as support and $2.90 as the nearer resistance level.
Valuation screens as undervalued: a P/E of 15.0 sits in line with the sector average of 15.6. Consensus targets land 82.3% above where the shares trade now. Revenue is contracting at 3.0% on a -16.3% profit margin. The 3.41% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 8 — high. With 30-day volatility of 40.7%, a beta of 0.75 and a maximum drawdown of 36.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.
Valuation screens as undervalued: a P/E of 15.0 sits in line with the sector average of 15.6. Consensus targets land 82.3% above where the shares trade now. Revenue is contracting at 3.0% on a -16.3% profit margin. The 3.41% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 8 — high. With 30-day volatility of 40.7%, a beta of 0.75 and a maximum drawdown of 36.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.
Top Market Events
Seeking Alpha1monGrupo Televisa's Q2 Earnings: What May Matter Most Is Not In The ReportGrupo Televisa remains a...Detailed price information for Grupo Televisa S.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked below long-term ones
- RSI at 21.7 signals oversold conditions
- Trading below the 200-day average of 2.89
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- RSI at 21.7 signals oversold conditions
- P/E of 15.0 versus sector average of 15.6
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 15.0 versus sector average of 15.6
- Negative profit margin of -16.3%
- Analyst targets imply +82.3% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth-3.00%
Profit Margin-16.26%
P/E Ratio15.0
ROE-7.96%
ROA1.73%
Debt/Equity78.64
P/B Ratio0.2
Op. Cash Flow$23.0B
Free Cash Flow$5.3B
Industry P/E15.6
Technical Analysis
TrendBearish
RSI21.7
Support$2.18
Resistance$2.90
MA 20$2.60
MA 50$2.71
MA 200$2.89
MACDBearish
VolumeIncreasing
Fear & Greed Index89.8
Valuation
Fair Value$37.18
Target Price$3.99
Upside/Downside82.32%
GradeUndervalued
TypeValue
Dividend Yield3.41%
Risk Assessment
Beta0.75
Volatility40.73%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.